Clinical Outcomes Associated With Rates of Sulfonylurea Use Among PhysiciansByKatalin Bognar, PhD,Kelly Fee Bell, PharmD, MS Phr,Darius Lakdawalla, PhD,Anshu Shrestha, PhD,Julia Thornton Snider, PhD,Nina Thomas, MPH,Dana Goldman, PhDJuly 8th 2013
Comparative Effectiveness Research and Formulary Placement: The Case of DiabetesByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MAJuly 2nd 2013
BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart DiseaseByMarj P. Zimmerman, MS, BSPharm,Stanton R. MehrJuly 2nd 2013
Diabetes Apps: Impacting Patients' Lives Maximizing the Use of Mobile Applications for Patients with Diabetes MellitusByKrisy-Ann Thornby, PharmD,Nicole Edquist, PharmDJuly 2nd 2013
Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MDByStanton R. MehrJuly 1st 2013
